In pregnancies at risk of hemolytic disease of the fetus and newborn (HDFN), amniocentesis is used to identify the fetus’s ...
Learn about why delayed hemolysis occurs, how it can affect newborns diagnosed with HDFN and how it can be treated.
A case report described an infant with concurrent HDFN and SMA who was succesfully treated with an onasemnogene abeparvovec infusion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback